Used in pharmaceutical research as a key intermediate for synthesizing bioactive compounds targeting central nervous system disorders. Shows potential in the development of agents for neurodegenerative diseases due to its structural affinity with monoamine modulators. Also explored for anti-inflammatory and antioxidant applications in preclinical studies. Its fused heterocyclic framework enhances metabolic stability, making it suitable for drug design requiring improved pharmacokinetics.